STRATA CRITICAL MEDICAL, INC. Business Acquisition, Pro Forma Revenue
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Business Acquisition, Pro Forma Revenue of $76.69 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma revenue for the quarter ending 2026-06-30 was $76.69M, a 14.95% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma revenue for the quarter ending 2025-12-31 was $63.58M, a 31.08% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma revenue for the quarter ending 2025-09-30 was $66.27M, a 38.58% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma revenue for the quarter ending 2025-06-30 was $66.72M.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma revenue for fiscal 2025 was $243.03M, a 28.47% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma revenue for fiscal 2024 was $189.17M.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma revenue for fiscal 2022 was $169.49M.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma revenue for fiscal 2021 was $69.14M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $76.69M 10-Q · filed 2026-08-04 | $149.57M 10-Q · filed 2026-08-04 | ||
| 2025-12-31 | $63.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $129.84M derived: sum of 2 quarters · filed 2026-03-03 | $196.56M derived: sum of 3 quarters · filed 2026-08-04 | $243.03M 10-K · filed 2026-03-03 |
| 2025-09-30 | $66.27M 10-Q · filed 2025-11-10 | $132.98M derived: sum of 2 quarters · filed 2026-08-04 | $179.45M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $66.72M 10-Q · filed 2026-08-04 | $121.42M 10-Q · filed 2026-08-04 | ||
| 2024-12-31 | $48.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $96.32M derived: sum of 2 quarters · filed 2026-03-03 | $189.17M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $47.82M 10-Q · filed 2025-11-10 | $140.66M 10-Q · filed 2025-11-10 | ||
| 2022-12-31 | $37.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $94.37M derived: sum of 2 quarters · filed 2024-03-12 | $169.49M 10-K · filed 2024-03-12 | |
| 2022-09-30 | $56.57M 10-Q · filed 2022-11-10 | $131.69M 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $27.52M 10-K · filed 2023-03-16 | $59.88M derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2021-09-30 | $32.35M 10-Q · filed 2022-11-10 | $59.16M 10-Q · filed 2022-11-10 | $69.14M 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |